Abstract
INTRODUCTION
Hydro-alcohol solvent systems are extensively used in the pharmaceutical field to apply functional and/or nonfunctional coating of tablets. Good product performance, including uniformity of coating and drug release, is a strong function of these coatings. Uniformity of tablet coating is extremely important as it affects the organoleptic quality of tablets and functionality of the coating, especially for modified release formulations
1,2
. The texture of coated membranes can affect drug release and lag time, which are important parameters in modified-release oral dosage forms
1-3
. Among modified-release oral dosage forms, increasing interest has been shown in systems designed to achieve time-specific (delayed, pulsatile) and site-specific delivery of drugs 4, 5 . In particular, systems for delayed release are meant to deliver the active principle after a programmed period following administration. These systems constitute a relatively new class of devices, the importance of which is especially connected with recent advances in chronopharmacology 6 .
By now it is well-known that the symptomatology of a large number of pathologies as well as the pharmacokinetics and pharmacodynamics of several drugs follow temporal rhythms, often resulting in circadian variations. Therefore, the possibility of exploiting delayed release to perform chronotherapy is quite appealing for those diseases. The delay in the onset of release has so far mainly been achieved through osmotic mechanism, coating with hydrophilic or hydrophobic layers as swellable and semi permeable films, swelling, and erodible plug sealing of insoluble capsule body
7
. In addition, multiple coating technology has been applied to chronopharmaceutical dosage forms to achieve the desired lag time and release of drug 8 
.
In the present investigation, a combination of approaches was used to develop the coated tablet formulation. HPMC was applied as a swelling layer while Eudragit RSPO/RLPO was used to provide a semi-permeable membrane for delayed release. The study mainly focused on the investigation of the influence of hydro-alcohol coating solvent ratio (water/ethanol) on the surface texture and drug release lag time of a coated porous osmotic tablet. Theophylline (TP), which is a useful drug in the management of nocturnal asthma, was used as the test drug in view of its effectiveness when administered at specific times in relation to onset of symptoms
9,10
.
EXPERIMENTAL Materials

Theophylline
(Bukul Aromatics and Chemicals., India) was chosen as the model drug for this study; methacrylic acid copolymers (Eudragit ® RS-PO and RL-PO) were supplied free of charge by JJ-Degussa Chemicals, Malaysia. Triethylcitrate [TEC] (Fluka, Germany) was selected as plasticizer while hydroxylpropyl methylcellulose (Methocel E5) was obtained free of charge from Colorcon Asea Specific, Singapore. Low-substituted hydroxypropyl cellulose was received as a gift from Shin-Etsu Chemicals, Japan. Sodium chloride (RM Chemicals, Malaysia) was used as the osmotic agent. All other chemicals used were of analytical or reagent grade.
Methods
As mentioned in the introduction, the objective of the work was to study the effect of solvent ratio on coating texture and the lag time for drug release. The designed osmotic tablet will be further developed to follow pulsatile release. The designed pulsatile tablet is based on combination of two approaches previously attempted: swelling and osmotic pumping mechanism. The pulsatile tablet was fabricated into three stages: first, the drug (TP) was directly compressed with the osmotic agent (NaCl) and super-disintegrant (LHPC-LH-11); second, tablets were coated with a low viscosity swelling layer (HPMC-E5); third, the tablets were subsequently coated with pHindependent methacrylic acid copolymers (Eudragit RSPO and RLPO) as a semipermeable membrane with TEC as pore forming agent.
Preparation of core tablets
Tablet cores containing theophylline [TP] (5mg/tablet) were prepared according to the following composition (w/w): theophylline (5%), sodium chloride (30%), microcrystalline
, magnesium stearate (0.5%) and talc (0.5%). Sodium chloride was pre-screened through a sieve with an aperture of 120µ. Magnesium stearate and talc were similarly screened through a sieve with an aperture of 250µ. All the ingredients were mixed for 15 min and sieved through a mesh with an aperture of 420µ five times. Tablets were directly compressed from the mixture using 6.05 mm shallow-concaved punches on ClitPress High Speed tablet machine (Chemunda Pharma Machine, India). Compression force was set such to yield tablets with a hardness of 4.5 ± 0.5 kg/cm 2 . Tablet hardness was monitored using a tablet hardness tester (model YD-2, Vanguard Pharmaceutical machinery Inc, China).
Preparation of coating formulations
Varying ratios of water and alcohol (as shown in Table 1 ) were mixed and HPMC (5% w/w) dispersed in each of the solvent by stirring at room temperature for 5 h. Polyethylene glycol (PEG 400) [1% w/w] was then added and stirred for 15 min.
Eudragit RSPO/RLPO blends (see Table 1) were similarly prepared at room temperature by adding the polymers slowly to the solvent with stirring. TEC, talc and PEG 6000 were added and stirred further for 30 min.
The viscosity of HPMC coating solution was measured with a Brookfield viscometer, USA.
Coating method
The tablets were warmed in an oven for 15 min at 45 ± 0.5 O C and transferred to a coating facility (Kothari Pharma Overseas, India). HPMC was applied as a swelling layer by spraying. After drying for 15 min in an oven at 50.0 ± 0.5 o C, the tablets were coated with the Eudragit formulation to provide a semi-permeable membrane, based on the coating parameters shown in Table 1 . The ratio of Eudragit RS to RL was 2:1. The coating level was determined based on the weight gain of 20 placebo tablets, which were coated at the same time as the test tablets. The tablets were dried in an oven at 55 ± 0.5 o C for 4 h to remove residual solvent from the coating.
Assessment of the morphology of coated tablet surface
Double layer coated tablets were coated with gold on one side by an ion sputter coater (Polaron SC515, Fisons Instruments, UK) at 50 mA for 120 sec. Gold coated surface of tablet was evaluated by scanning electron microscopy (Leo Supra 50 VP, Germany) to assess the surface texture of the Eudragit polymer layer.
In vitro evaluation of drug release lag time
In vitro drug release (dissolution) studies were performed as per USP paddle method at 37.0 ± 0.5 o C in simulated gastric fluid (SGF, pH 1.2) and simulated intestinal fluid (SIF, pH 6.8) with the paddle rotating at 100 rpm. Samples (5 mL) were withdrawn at predetermined time intervals and replaced with equal volume of media. The concentration of TP released from the coated tablets was measured by UV absorption spectroscopy (Hitachi U-2000, Japan) at 276 nm. 
RESULTS
Viscosity of HPMC coating solution:
No significant change was found in the viscosity of HPMC solution prepared with varying ratios of hydroalcohol solutions. Viscosity was 5.5 ± 0.1, 5.6 ± 0.12, 5.6 ± 0.2, and 5.7 ± 0.1 cps (mean ± SD, n=3) for water/alcohol ratio of 80:14, 60:34, 45:49, and 30:64, respectively. This indicates that drug release lag time would not have been influenced by the viscosity of HPMC coating solution.
In vitro theophylline release lag time
In vitro release lag time data for the osmotic tablets in SGF (see Fig 1) and SIF (see Fig 2) did not differ significantly (P < 0.05). Tablets 
Surface morphology of coated tablets
The surface morphology and cross-sectional view of coated tablets evaluated by SEM are shown in Fig 3. Tablets coated with polymers using water/alcohol solvent ratios 80:14 and 30:64 resulted in a rough surface with cracks (see Fig 3a and Fig 3d) while those based on water/alcohol ratio of 60:34 showed the smoothest surface (see Fig 3b) with very fine pores. The coating solution based on a water/alcohol ratio of 45:49 showed a slightly rough surface with few cracks (see Fig 3c) .
DISCUSSION
Directly compressed theophylline tablets can be easily coated with hydro-alcohol coating formulations of HPMC and methacrylic acid co-polymers using spray coating method. The surface morphology of the tablets was satisfactory for those coated with formulations based on water/alcohol solvent 
F2 F1 F3 F4
ratio of 60:34 (Fig 3b) leaving a good film formation on the tablet core
11
. Increasing either the amount of water or alcohol in the coating solution beyond this ratio resulted in increase in coated surface roughness (F1 and F4) as shown in Figs 3a and 3d . Roughness of coated surface contributed to decreased drug release lag time which could be due to the formation of fractures in the coated layer as a result of low mechanical strength 13, 14 . These fractures might have facilitated rapid movement of dissolution media into the tablets since high osmotic pressure exists across the membrane and dissolution media due to the presence of osmotic agent (NaCl) in the tablet core.
Surface roughness of the coated film (see Fig  3a) was high in tablets coated with the formulation based on water/alcohol ratio of 80:14 (F1). The roughness and fracture of F1 coated tablets could be due to the prolonged presence of residual solvent on the surface of the tablet as a result of slow evaporation rate and sticking of the tablets to the coating pan during the tablet coating process. Slow evaporation in F1 could be due to the high proportion of water in the coating solvent system. On the other hand, the rough surface of tablets coated with formulation based on water/alcohol solvent ratio of 30:64 (F4), as shown in Fig 3d, can be attributed to the rapid rate of solvent evaporation (due to the high alcohol content of the solvent system), which did not allow formation of continuous coating film, thus leaving behind cracks after tablet during drying. Rapid evaporation is attributed to the presence of a high proportion of volatile ethanol. This contrasts with coated tablets based water/alcohol solvent ratio of 60:34 (F2) which gave a smooth surface (Fig  3b) as the alcohol proportion of the solvent mixture seems appropriate for optimum solvent evaporation, resulting in the formation of a smooth film coating. Such a smooth film would be expected to show resistance to penetration of dissolution medium and hence passage of dissolution fluid into the tablet core, leading to increased lag time 12 
.
Coated tablets based on water/alcohol solvent ratio of 45:49 (F3) showed moderate surface smoothness (Fig 3c) . This may be due to the higher proportion of alcohol than in coating formulation F2 which leads to a faster evaporation of coating solvent than the optimum solvent evaporation rate observed for F2. Expectedly, cracks and pores in the coating resulted in burst release for F1 and F4 coating formulation.
The lack of significant difference (p < 0.05) between the lag time in simulated gastric fluid (pH 1.2) and simulated intestinal fluid (pH 6.8) may be due to the outer coat which are composed of methacrylic acid co-polymers whose solubility are pH-independent
15
. The similarity of the viscosity of HPMC solutions prepared with varying water/alcohol solvent mixtures would also mean that ratio of the solvent mixture would be unlikely to affect drug release lag time 
CONCLUSION
Based on the foregoing, it can be concluded that the formulation of theophylline osmotic tablets for pulsatile release with the desired lag time is feasible if the water/alcohol solvent ratio for HPMC and methacrylic acid co-polymers is carefully selected. In this regard, an optimum water/alcohol solvent ratio of 60:34 for the coating polymers was found. helpful comments and advice during scanning electron microscopic evaluation. Financial support for the work from Research and Innovation Division, Universiti Sains Malaysia (USM), Malaysia, is also acknowledged. Our special thank to USMFellowship for their continuous support.
